Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established treatment for aortic stenosis (AS) in patients at increased surgical risk. Up to 29% of patients annually experience major adverse cardiac and cerebrovascular events (MACCE) after TAVI. MicroRNAs (miRNA) are currently widel...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ceren Eyileten, Alicja Skrobucha, Miłosz Starczyński, Maria Boszko, Joanna Jarosz-Popek, Alex Fitas, Krzysztof J. Filipiak, Janusz Kochman, Zenon Huczek, Bartosz Rymuza, Radosław Wilimski, Mariusz Kuśmierczyk, Jolanta M. Siller-Matula, Marek Postula, Aleksandra Gąsecka
Format:	Artigo
Idioma:	Inglês
Publicat:	Via Medica 2024-02-01
Col·lecció:	Cardiology Journal
Matèries:	aortic stenosis transcatheter aortic valve implantation (TAVI) microRNA prognosis
Accés en línia:	https://journals.viamedica.pl/cardiology_journal/article/view/88863
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!